Labcorp Holdings Announces Q2 2025 Financial Results Release

Labcorp Holdings Inc. will release its Q2 2025 financial results on July 24, 2025, before the market opens. The company will host a conference call and webcast at 9 a.m. ET on the same day to discuss the financial outcomes. Investors can access the earnings press release and accompanying financial information on the Labcorp Investor Relations website.

Labcorp Holdings Inc. (NYSE: LH), a global leader in laboratory services, has scheduled the release of its Q2 2025 financial results for July 24, 2025, before the market opens. The company will host a conference call and webcast at 9:00 AM ET on the same day to discuss the financial outcomes [1][2].

Investors can access the earnings press release and accompanying financial information on Labcorp's Investor Relations website. A webcast replay will be available approximately two hours after the event and will be accessible until July 11, 2026 [1][2].

Labcorp, with its extensive network of laboratories, provides diagnostic services and drug development support to clients in approximately 100 countries. In 2024, the company supported more than 75% of new drug and therapeutic product approvals by the FDA, and performs over 700 million tests annually [1].

The company's financial performance in Q2 2025 is anticipated to provide insights into its continued growth and operational efficiency. Investors are encouraged to tune in to the conference call and webcast to gain a comprehensive understanding of the company's financial health and strategic direction.

References:
[1] https://www.biospace.com/press-releases/labcorp-to-announce-second-quarter-financial-results-on-july-24-2025
[2] https://www.stocktitan.net/news/LH/labcorp-to-announce-second-quarter-financial-results-on-july-24-2exos16yy23b.html